Search results for CD133

Anti-Hu CD133 Purified, Covalab, Ref 00122802

Anti-Hu CD133 APC, Covalab, Ref 00122803

Anti-Hu CD133 PE, Covalab, Ref 00122804

Anti-Hu CD133 Purified, Covalab, Ref 00123147

Anti-Hu CD133 APC, Covalab, Ref 00123148

Anti-Hu CD133 PE, Covalab, Ref 00123149

Anti-CD133 antibody [293C3], Abcam, AB252553

Anti-CD133 antibody [BLR093G], Abcam, AB276130

REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. This product is sold under License from Bethyl Laboratories, Inc.

Anti-CD133 antibody [EPR16508], Abcam, AB222782

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD133 antibody [HL1271], Abcam, AB317084